Clinical Trial Update: Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of zalutumumab in combination with chemotherapy and radiotherapy for head and neck squamous cell carcinoma was terminated; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Zalutumumab (zalutumumab)

Snippet

Sponsor: Genmab | Conditions: Head and Neck Cancer, Squamous Cell Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2011-12-23